Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion type Assertion NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_head.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion description "[EC is known for extensive epigenetic alterations, including overexpression of HDAC and DNMT enzymes, and the frequent epigenetic silencing of DNA repair genes such as MLH1, tumor suppressor genes PTEN, and progesterone receptor, which suggests a potentially high sensitivity of this type of cancer to HDAC inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_provenance.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion evidence source_evidence_literature NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_provenance.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion SIO_000772 23888962 NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_provenance.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion wasDerivedFrom befree-20150227 NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_provenance.
- NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_assertion wasGeneratedBy ECO_0000203 NP829771.RAaNGUVkOvPXV0dxpauObX0kZGVSOxyBVdotbvTCRBLAI130_provenance.